Clinical Nuclear Cardiology addresses the latest developments in technology, radiopharmaceuticals, molecular imaging, and perfusion imaging. Thoroughly revised to include 20 new chapters—Digital/Fast SPECT, Imaging in Revascularized Patients, and more—this new edition provides state-of-the-art guidance on key areas with stunning visuals. This is an invaluable resource no clinician or researcher in nuclear cardiology should be without.
1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Dedication - p. iii 6. Contributors - p. iii 7. Preface - p. iii 8. Videos - p. iii 9. Section 1: Radiopharmaceuticals/Tracer Kinetics - p. iii 10. List of Illustrations - p. iii 11. List of Tables - p. iii 12. Chapter 1: Overview of Tracer Kinetics and Cellular Mechanisms of Uptake - p. iii 13. Chapter 2: Principles of Myocardial Metabolism as They Relate to Imaging - p. iii 14. Chapter 3: Role of Intact Biological Models for Evaluation of Radiotracers - p. iii 15. Section 2: Instrumentation - p. iii 16. Chapter 4: SPECT Processing, Quantification, and Display - p. iii 17. Chapter 5: Single-Photon Emission Computed Tomography Artifacts - p. iii 18. Chapter 6: Attenuation/Scatter/Resolution Correction: Physics Aspects - p. iii 19. Chapter 7: Attenuation Correction and Scatter Correction of Myocardial Perfusion SPECT Images - p. iii 20. Chapter 8: Hybrid Cardiac Imaging - p. iii 21. Chapter 9: Digital/Fast SPECT: Systems and Software - p. iii 22. Chapter 10: Radiation Considerations for Cardiac Nuclear and Computed Tomography Imaging - p. iii 23. Chapter 11: State-of-the-Art Instrumentation for PET and SPECT Imaging in Small Animals - p. iii 24. Section 3: Ventricular Function - p. iii 25. Chapter 12: Cardiac Performance - p. iii 26. Chapter 13: Regional and Global Ventricular Function and Volumes from SPECT Perfusion Imaging - p. iii 27. Section 4: Perfusion Imaging - p. iii 28. Chapter 14: Coronary Artery Disease Detection: Exercise Stress SPECT - p. iii 29. Chapter 15: Coronary Artery Disease Detection: Pharmacologic Stress SPECT - p. iii 30. Chapter 16: Prognostic Implications of MPI Stress SPECT - p. iii 31. Chapter 17: Myocardial Perfusion: Magnetic Resonance Imaging - p. iii 32. Chapter 18: Myocardial Perfusion Imaging with Contrast Echocardiography - p. iii 33. Chapter 19: Diagnosis and Prognosis in Cardiac Disease Using Cardiac PET Perfusion Imaging - p. iii 34. Chapter 20: Coronary Artery Calcification: Pathogenesis, Imaging, and Risk Stratification - p. iii 35. Chapter 21: Coronary Artery Computed Tomography Angiography - p. iii 36. Chapter 22: PET/CT and SPECT/CT Hybrid Imaging - p. iii 37. Chapter 23: Comparison of Noninvasive Techniques for Myocardial Perfusion Imaging - p. iii 38. Chapter 24: Cost-Effectiveness of Myocardial Perfusion Single-Photon Emission Computed Tomography - p. iii 39. Chapter 25: Appropriate Use of Nuclear Cardiology - p. iii 40. Section 5: Disease/Gender-Specific Issues - p. iii 41. Chapter 26: Imaging in Women - p. iii 42. Chapter 27: Imaging for Preoperative Risk Stratification - p. iii 43. Chapter 28: Nuclear Imaging in Revascularized Patients with Coronary Artery Disease - p. iii 44. Chapter 29: Stress Myocardial Perfusion Imaging in Patients with Diabetes Mellitus - p. iii 45. Chapter 30: Radionuclide Imaging in Heart Failure - p. iii 46. Chapter 31: Imaging in Patients Receiving Cardiotoxic Chemotherapy - p. iii 47. Chapter 32: Mechanistic and Methodological Considerations for the Imaging of Mental Stress Ischemia - p. iii 48. Chapter 33: Myocardial Blood Flow Measurement: Evaluating Coronary Pathophysiology and Monitoring Therapy - p. iii 49. Section 6: Acute Coronary Syndromes - p. iii 50. Chapter 34: Imaging Patients with Chest Pain in the Emergency Department - p. iii 51. Chapter 35: Risk Stratification after Acute ST-Segment Elevation and Non-ST-Segment Elevation Myocardial Infarction - p. iii 52. Section 7: Viability - p. iii 53. Chapter 36: Pathophysiologic Basis of Hibernating Myocardium - p. iii 54. Chapter 37: Assessment of Myocardial Viability with Thallium-201 and Technetium-Based Agents - p. iii 55. Chapter 38: Assessment of Myocardial Viability with Positron Emission Tomography - p. iii 56. Chapter 39: Myocardial Viability: Comparison With Other Techniques - p. iii 57. Section 8: Tracer Specific Imaging Techniques - p. iii 58. Chapter 40: Imaging of Myocardial Metabolism - p. iii 59. Chapter 41: Cardiac Neurotransmission Imaging: Single-Photon Emission Computed Tomography - p. iii 60. Chapter 42: Cardiac Neurotransmission Imaging: Positron Emission Tomography - p. iii 61. Section 9: New Molecular Approaches - p. iii 62. Chapter 43: Molecular Imaging Approaches for Evaluation of Myocardial Pathophysiology: Angiogenesis, Ventricular Remodeling, Inflammation, and Cell Death - p. iii 63. Chapter 44: Radionuclide Imaging of Inflammation in Atheroma - p. iii 64. Chapter 45: Molecular Imaging of Gene Expression and Cell Therapy - p. iii 65. Chapter 46: Case 1 - p. iii 66. Chapter 47: Case 2 - p. iii 67. Chapter 48: Case 3 - p. iii 68. Chapter 49: Case 4 - p. iii 69. Chapter 50: Case 5 - p. iii 70. Chapter 51: Case 6 - p. iii 71. Chapter 52: Case 7 - p. iii 72. Chapter 53: Case 8 - p. iii 73. Chapter 54: Case 9 - p. iii 74. Chapter 55: Case 10 - p. iii 75. Chapter 56: Case 11 - p. iii 76. Chapter 57: Case 12 - p. iii 77. Chapter 58: Case 13 - p. iii 78. Chapter 59: Case 14 - p. iii 79. Chapter 60: Case 15 - p. iii 80. Chapter 61: Case 16 - p. iii 81. Chapter 62: Case 17 - p. iii 82. Chapter 63: Case 18 - p. iii 83. Chapter 64: Case 19 - p. iii 84. Chapter 65: Case 20 - p. iii 85. Chapter 66: Case 21 - p. iii 86. Chapter 67: Case 22 - p. iii 87. Chapter 68: Case 23 - p. iii 88. Chapter 69: Case 24 - p. iii 89. Chapter 70: Case 25 - p. iii 90. Chapter 71: Case 26 - p. iii 91. Chapter 72: Case 27 - p. iii 92. Chapter 73: Case 28 - p. iii 93. Chapter 74: Case 29 - p. iii 94. Chapter 75: Case 30 - p. iii 95. Chapter 76: Case 31 - p. iii 96. Chapter 77: Case 32 - p. iii 97. Chapter 78: Case 33 - p. iii 98. Chapter 79: Case 34 - p. iii 99. Chapter 80: Case 35 - p. iii 100. Index - p. iii
Clinical Nuclear Cardiology addresses the latest developments in technology, radiopharmaceuticals, molecular imaging, and perfusion imaging. Thoroughly revised to include 20 new chapters—Digital/Fast SPECT, Imaging in Revascularized Patients, and more—this new edition provides state-of-the-art guidance on key areas with stunning visuals. This is an invaluable resource no clinician or researcher in nuclear cardiology should be without.
1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Dedication - p. iii 6. Contributors - p. iii 7. Preface - p. iii 8. Videos - p. iii 9. Section 1: Radiopharmaceuticals/Tracer Kinetics - p. iii 10. List of Illustrations - p. iii 11. List of Tables - p. iii 12. Chapter 1: Overview of Tracer Kinetics and Cellular Mechanisms of Uptake - p. iii 13. Chapter 2: Principles of Myocardial Metabolism as They Relate to Imaging - p. iii 14. Chapter 3: Role of Intact Biological Models for Evaluation of Radiotracers - p. iii 15. Section 2: Instrumentation - p. iii 16. Chapter 4: SPECT Processing, Quantification, and Display - p. iii 17. Chapter 5: Single-Photon Emission Computed Tomography Artifacts - p. iii 18. Chapter 6: Attenuation/Scatter/Resolution Correction: Physics Aspects - p. iii 19. Chapter 7: Attenuation Correction and Scatter Correction of Myocardial Perfusion SPECT Images - p. iii 20. Chapter 8: Hybrid Cardiac Imaging - p. iii 21. Chapter 9: Digital/Fast SPECT: Systems and Software - p. iii 22. Chapter 10: Radiation Considerations for Cardiac Nuclear and Computed Tomography Imaging - p. iii 23. Chapter 11: State-of-the-Art Instrumentation for PET and SPECT Imaging in Small Animals - p. iii 24. Section 3: Ventricular Function - p. iii 25. Chapter 12: Cardiac Performance - p. iii 26. Chapter 13: Regional and Global Ventricular Function and Volumes from SPECT Perfusion Imaging - p. iii 27. Section 4: Perfusion Imaging - p. iii 28. Chapter 14: Coronary Artery Disease Detection: Exercise Stress SPECT - p. iii 29. Chapter 15: Coronary Artery Disease Detection: Pharmacologic Stress SPECT - p. iii 30. Chapter 16: Prognostic Implications of MPI Stress SPECT - p. iii 31. Chapter 17: Myocardial Perfusion: Magnetic Resonance Imaging - p. iii 32. Chapter 18: Myocardial Perfusion Imaging with Contrast Echocardiography - p. iii 33. Chapter 19: Diagnosis and Prognosis in Cardiac Disease Using Cardiac PET Perfusion Imaging - p. iii 34. Chapter 20: Coronary Artery Calcification: Pathogenesis, Imaging, and Risk Stratification - p. iii 35. Chapter 21: Coronary Artery Computed Tomography Angiography - p. iii 36. Chapter 22: PET/CT and SPECT/CT Hybrid Imaging - p. iii 37. Chapter 23: Comparison of Noninvasive Techniques for Myocardial Perfusion Imaging - p. iii 38. Chapter 24: Cost-Effectiveness of Myocardial Perfusion Single-Photon Emission Computed Tomography - p. iii 39. Chapter 25: Appropriate Use of Nuclear Cardiology - p. iii 40. Section 5: Disease/Gender-Specific Issues - p. iii 41. Chapter 26: Imaging in Women - p. iii 42. Chapter 27: Imaging for Preoperative Risk Stratification - p. iii 43. Chapter 28: Nuclear Imaging in Revascularized Patients with Coronary Artery Disease - p. iii 44. Chapter 29: Stress Myocardial Perfusion Imaging in Patients with Diabetes Mellitus - p. iii 45. Chapter 30: Radionuclide Imaging in Heart Failure - p. iii 46. Chapter 31: Imaging in Patients Receiving Cardiotoxic Chemotherapy - p. iii 47. Chapter 32: Mechanistic and Methodological Considerations for the Imaging of Mental Stress Ischemia - p. iii 48. Chapter 33: Myocardial Blood Flow Measurement: Evaluating Coronary Pathophysiology and Monitoring Therapy - p. iii 49. Section 6: Acute Coronary Syndromes - p. iii 50. Chapter 34: Imaging Patients with Chest Pain in the Emergency Department - p. iii 51. Chapter 35: Risk Stratification after Acute ST-Segment Elevation and Non-ST-Segment Elevation Myocardial Infarction - p. iii 52. Section 7: Viability - p. iii 53. Chapter 36: Pathophysiologic Basis of Hibernating Myocardium - p. iii 54. Chapter 37: Assessment of Myocardial Viability with Thallium-201 and Technetium-Based Agents - p. iii 55. Chapter 38: Assessment of Myocardial Viability with Positron Emission Tomography - p. iii 56. Chapter 39: Myocardial Viability: Comparison With Other Techniques - p. iii 57. Section 8: Tracer Specific Imaging Techniques - p. iii 58. Chapter 40: Imaging of Myocardial Metabolism - p. iii 59. Chapter 41: Cardiac Neurotransmission Imaging: Single-Photon Emission Computed Tomography - p. iii 60. Chapter 42: Cardiac Neurotransmission Imaging: Positron Emission Tomography - p. iii 61. Section 9: New Molecular Approaches - p. iii 62. Chapter 43: Molecular Imaging Approaches for Evaluation of Myocardial Pathophysiology: Angiogenesis, Ventricular Remodeling, Inflammation, and Cell Death - p. iii 63. Chapter 44: Radionuclide Imaging of Inflammation in Atheroma - p. iii 64. Chapter 45: Molecular Imaging of Gene Expression and Cell Therapy - p. iii 65. Chapter 46: Case 1 - p. iii 66. Chapter 47: Case 2 - p. iii 67. Chapter 48: Case 3 - p. iii 68. Chapter 49: Case 4 - p. iii 69. Chapter 50: Case 5 - p. iii 70. Chapter 51: Case 6 - p. iii 71. Chapter 52: Case 7 - p. iii 72. Chapter 53: Case 8 - p. iii 73. Chapter 54: Case 9 - p. iii 74. Chapter 55: Case 10 - p. iii 75. Chapter 56: Case 11 - p. iii 76. Chapter 57: Case 12 - p. iii 77. Chapter 58: Case 13 - p. iii 78. Chapter 59: Case 14 - p. iii 79. Chapter 60: Case 15 - p. iii 80. Chapter 61: Case 16 - p. iii 81. Chapter 62: Case 17 - p. iii 82. Chapter 63: Case 18 - p. iii 83. Chapter 64: Case 19 - p. iii 84. Chapter 65: Case 20 - p. iii 85. Chapter 66: Case 21 - p. iii 86. Chapter 67: Case 22 - p. iii 87. Chapter 68: Case 23 - p. iii 88. Chapter 69: Case 24 - p. iii 89. Chapter 70: Case 25 - p. iii 90. Chapter 71: Case 26 - p. iii 91. Chapter 72: Case 27 - p. iii 92. Chapter 73: Case 28 - p. iii 93. Chapter 74: Case 29 - p. iii 94. Chapter 75: Case 30 - p. iii 95. Chapter 76: Case 31 - p. iii 96. Chapter 77: Case 32 - p. iii 97. Chapter 78: Case 33 - p. iii 98. Chapter 79: Case 34 - p. iii 99. Chapter 80: Case 35 - p. iii 100. Index - p. iii
